2020
DOI: 10.1111/cup.13775
|View full text |Cite
|
Sign up to set email alerts
|

Molecular analysis of atypical deep penetrating nevus progressing to melanoma

Abstract: Deep penetrating nevi (DPN) are dermal-based, heavily pigmented melanocytic proliferations primarily resulting from mutations in B-catenin and BRAF or, less commonly, NRAS. DPNs are considered to be intermediate grade tumors which are stable with low risk of malignant transformation. The precise risk for transformation is unknown. Only rare cases of DPN progressing to melanoma have been described. We present a case of a 53-year-old female with a blue-black thigh lesion, on histopathology illustrating a melanoc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
19
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 15 publications
(20 citation statements)
references
References 17 publications
1
19
0
Order By: Relevance
“…DPN can occur as “pure” with predominant population of the above‐mentioned components or as “combined” in combination with common acquired nevus (CAN) and less commonly with blue nevus. DPNs are also described with spectrum of borderline melanocytic neoplasms and DPN‐like melanomas with positive lymph nodes 1,2 . Molecular profiling of DPNs has shown to harbor additional activating β‐catenin/pathway mutation along with MAP Kinase pathway mutations that are commonly identified in CANs, confirming that these lesions are genetically distinct from melanocytic neoplasm that share similar related clinical and histopathologic features such as blue nevus, Spitz nevi, and pigmented melanocytomas 3,4 .…”
Section: Figurementioning
confidence: 89%
“…DPN can occur as “pure” with predominant population of the above‐mentioned components or as “combined” in combination with common acquired nevus (CAN) and less commonly with blue nevus. DPNs are also described with spectrum of borderline melanocytic neoplasms and DPN‐like melanomas with positive lymph nodes 1,2 . Molecular profiling of DPNs has shown to harbor additional activating β‐catenin/pathway mutation along with MAP Kinase pathway mutations that are commonly identified in CANs, confirming that these lesions are genetically distinct from melanocytic neoplasm that share similar related clinical and histopathologic features such as blue nevus, Spitz nevi, and pigmented melanocytomas 3,4 .…”
Section: Figurementioning
confidence: 89%
“…At the genetic level, besides alterations in the β-catenin pathway, the tumor carried mutations in IDH1 and NRAS (codon 61) genes. In the context of DPN, NRAS mutations have been reported thus far in sporadic observations, including a combined nevus with a DPN component and a case of atypical DPN progressing to melanoma [ 33 , 34 ]. In addition, a subset of melanomas with IDH1 mutations that are significantly associated with co-existing NRAS mutations has been described [ 29 ].…”
Section: Discussionmentioning
confidence: 99%
“…This further supports the concept that the more conventional melanoma was the more aggressive portion of the tumor. A recent report of an atypical DPN recurring and progressing as a melanoma showed a hotspot TERT promoter mutation in the melanoma that was not present in the precursor lesion (Isales et al., 2020).…”
Section: Discussionmentioning
confidence: 99%